The United State Food and Drug Administration gives approval for prescription drugs that are shown to be safe and effective to treat specific conditions. But once the drug is available, physicians can prescribe it for other “off label” uses, the positive therapeutic side effects that are discovered by the medical communities’ own information networks. The pharmaceutical manufacturers would like to be able to tell other doctors about these positive side effects, but they are barred from such “off label marketing” practices except under very narrow conditions.
Galloway, C. (2003), "Misplaced marketing Misplaced fears of off label prescription drug marketing", Journal of Consumer Marketing, Vol. 20 No. 6, pp. 513-515. https://doi.org/10.1108/07363760310499084Download as .RIS
MCB UP Ltd
Copyright © 2003, MCB UP Limited